Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases
Ducatman, B. S., Scheithauer, B. W., Piepgras, D. G., Reiman, H. M., & Ilstrup, D. M. (1986) · Cancer · doi:10.1002/1097-0142(19860515)57:10<2006::aid-cncr2820571022>3.0.co;2-6 · Cited by 1,581
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,475 · cited 5×
“(1) Headache, headache with migraine, epilepsy, and sleep”
BackgroundInfluentialBrown, A. S., Brummel‐Smith, K., Burgess, L., D'Agostino, R. B., Goldschmidt, J. W., Halter, J. B., Hazzard, W. R., Jahnigen, D. W., Phelps, C., Raskind, M., et al. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb02362.x · Cited by 1,331
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
Evans, D. G. R., Baser, M. E., McGaughran, J., Sharif, S., Howard, E., & Moran, A. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.311 · Cited by 1,282
Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?
Lenders, J. W. M., Pacak, K., Walther, M. M., Linehan, W. M., Mannelli, M., Friberg, P., Keiser, H. R., Goldstein, D. S., & Eisenhofer, G. (2002) · JAMA · doi:10.1001/jama.287.11.1427 · Cited by 1,134
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082 · cited 6×
“(2) A tumor-independent NF1 neuropathy is recognized but rare and varied in symptomology and progression.”
BackgroundInfluentialGene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Easton, D. F., Pharoah, P. D. P., Antoniou, A. C., Tischkowitz, M., Tavtigian, S. V., Nathanson, K. L., Devilee, P., Meindl, A., Couch, F. J., Southey, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1501341 · Cited by 920
Self-citationVON RECKLINGHAUSEN NEUROFIBROMATOSIS: A CLINICAL AND POPULATION STUDY IN SOUTH-EAST WALES
HUSON, S. M., HARPER, P. S., & COMPSTON, D. A. S. (1988) · Brain · doi:10.1093/brain/111.6.1355 · Cited by 686
Second malignant neoplasms in children: an update from the Late Effects Study Group.
Meadows, A. T., Baum, E., Fossati-Bellani, F., Green, D., Jenkin, R. D., Marsden, B., Nesbit, M., Newton, W., Oberlin, O., & Sallan, S. G. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.4.532 · Cited by 481
Shannon, K. M., O'Connell, P., Martin, G. A., Paderanga, D., Olson, K., Dinndorf, P., & McCormick, F. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300903 · Cited by 444
Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1
Uusitalo, E., Rantanen, M., Kallionpää, R. A., Pöyhönen, M., Leppävirta, J., Ylä-Outinen, H., Riccardi, V. M., Pukkala, E., Pitkäniemi, J., Peltonen, S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.3576 · Cited by 418
Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force
Friedman, J. M., Arbiser, J., Epstein, J. A., Gutmann, D. H., Huot, S. J., Lin, A. E., Mcmanus, B., & Korf, B. R. (2002) · Genetics in Medicine · doi:10.1097/00125817-200205000-00002 · Cited by 402
Self-citationOderich, G. S., Sullivan, T. M., Bower, T. C., Gloviczki, P., Miller, D. V., Babovic-Vuksanovic, D., Macedo, T. A., & Stanson, A. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.03.055 · Cited by 396
Zöller, M. E. T., Rembeck, B., Odén, A., Samuelsson, M., & Angervall, L. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970601)79:11<2125::aid-cncr9>3.3.co;2-b · Cited by 395
Amar, L., Servais, A., Gimenez-Roqueplo, A.-P., Zinzindohoue, F., Chatellier, G., & Plouin, P.-F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1398 · Cited by 390
Upadhyaya, M., Huson, S. M., Davies, M., Thomas, N., Chuzhanova, N., Giovannini, S., Evans, D. G., Howard, E., Kerr, B., Griffiths, S., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/510781 · Cited by 362
Self-citationVON RECKLINGHAUSEN′S DISEASE AND PHEOCHROMOCYTOMAS
Walther, M. M., Herring, J., Enquist, E., Keiser, H. R., & Linehan, W. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68171-2 · Cited by 361
Malignant Peripheral Nerve Sheath Tumors
Farid, M., Demicco, E. G., Garcia, R., Ahn, L., Merola, P. R., Cioffi, A., & Maki, R. G. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0328 · Cited by 354
Counselling framework for moderate-penetrance cancer-susceptibility mutations
Tung, N., Domchek, S. M., Stadler, Z., Nathanson, K. L., Couch, F., Garber, J. E., Offit, K., & Robson, M. E. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.90 · Cited by 314
Self-citationElevated Risk for MPNST in NF1 Microdeletion Patients
De Raedt, T., Brems, H., Wolkenstein, P., Vidaud, D., Pilotti, S., Perrone, F., Mautner, V., Frahm, S., Sciot, R., & Legius, E. (2003) · The American Journal of Human Genetics · doi:10.1086/374821 · Cited by 310
Incidence and Mortality of Neurofibromatosis: A Total Population Study in Finland
Uusitalo, E., Leppävirta, J., Koffert, A., Suominen, S., Vahtera, J., Vahlberg, T., Pöyhönen, M., Peltonen, J., & Peltonen, S. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.465 · Cited by 308 · cited 6×
“(3) NF1-associated vasculopathy affects small, medium, and large vessels (primarily arteries); venous and pulmonary artery involvement also may occur.”
BackgroundInfluentialFerner, R. E., Golding, J. F., Smith, M., Calonje, E., Jan, W., Sanjayanathan, V., & O’Doherty, M. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm450 · Cited by 286
Insights into the pathogenesis of neurofibromatosis 1 vasculopathy
Hamilton, S., & Friedman, J. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580501.x · Cited by 280
Kolberg, M., Holand, M., Agesen, T. H., Brekke, H. R., Liestol, K., Hall, K. S., Mertens, F., Picci, P., Smeland, S., & Lothe, R. A. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos287 · Cited by 270
Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1
Lin, A. E., Birch, P. H., Korf, B. R., Tenconi, R., Niimura, M., Pöyhönen, M., Uhas, K. A., Sigorini, M., Virdis, R., Romano, C., et al. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20001113)95:2<108::aid-ajmg4>3.0.co;2-0 · Cited by 265
Self-citationAssessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1
Mautner, V.-F., Asuagbor, F. A., Dombi, E., Fünsterer, C., Kluwe, L., Wenzel, R., Widemann, B. C., & Friedman, J. M. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-011 · Cited by 260
Sharif, S., Moran, A., Huson, S. M., Iddenden, R., Shenton, A., Howard, E., & Evans, D. G. R. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.049346 · Cited by 242
A prospective study of neurofibromatosis type 1 cancer incidence in the UK
Walker, L., Thompson, D., Easton, D., Ponder, B., Ponder, M., Frayling, I., & Baralle, D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603227 · Cited by 240
Kroep, J. R., Ouali, M., Gelderblom, H. A. J., Cesne, A. L., Dekker, T. J. A., Glabbeke, M. M. V., Hogendoorn, P. C. W., & Hohenberger, P. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq338 · Cited by 240
Quality-of-Life Impairment in Neurofibromatosis Type 1: A Cross-sectional Study of 128 Cases
Wolkenstein, P., Zeller, J., Revuz, J., Ecosse, E., & Leplège, A. (2001) · Archives of Dermatology · doi:10.1001/archderm.137.11.1421 · Cited by 208
Evans, D. G. R., O'Hara, C., Wilding, A., Ingham, S. L., Howard, E., Dawson, J., Moran, A., Scott-Kitching, V., Holt, F., & Huson, S. M. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.113 · Cited by 197
Health Supervision for Children With Neurofibromatosis
Hersh, J. H., & Committee on Genetics (2008) · Pediatrics · doi:10.1542/peds.2007-3364 · Cited by 184
Intellectual impairment in neurofibromatosis 1
Ferner, R. E., Hughes, R. A. C., & Weinman, J. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00022-6 · Cited by 183
Spinal deformity in neurofibromatosis type-1: diagnosis and treatment
Tsirikos, A. I., Saifuddin, A., & Noordeen, M. H. (2005) · European Spine Journal · doi:10.1007/s00586-004-0829-7 · Cited by 175
Mautner, V.-F., Kluwe, L., Friedrich, R. E., Roehl, A. C., Bammert, S., Högel, J., Spöri, H., Cooper, D. N., & Kehrer-Sawatzki, H. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.075937 · Cited by 173
Neurofibromatosis type 1 and pregnancy
Dugoff, L., & Sujansky, E. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19961202)66:1<7::aid-ajmg2>3.0.co;2-r · Cited by 168
Misery, L., Brenaut, E., Le Garrec, R., Abasq, C., Genestet, S., Marcorelles, P., & Zagnoli, F. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.99 · Cited by 159
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1)
Gutmann, D. H., Rasmussen, S. A., Wolkenstein, P., MacCollin, M. M., Guha, A., Inskip, P. D., North, K. N., Poyhonen, M., Birch, P. H., & Friedman, J. M. (2002) · Neurology · doi:10.1212/wnl.59.5.759 · Cited by 158
Warbey, V. S., Ferner, R. E., Dunn, J. T., Calonje, E., & O’Doherty, M. J. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-1038-0 · Cited by 158
Watson, K. L., Sannaa, G. A. A., Kivlin, C. M., Ingram, D. R., Landers, S. M., Roland, C. L., Cormier, J. N., Hunt, K. K., Feig, B. W., Guadagnolo, B. A., et al. (2016) · Journal of neurosurgery · doi:10.3171/2015.12.jns152443 · Cited by 158
Brems, H., Park, C., Maertens, O., Pemov, A., Messiaen, L. M., Upadhyaya, M., Claes, K., Beert, E., Peeters, K., Mautner, V., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1752 · Cited by 153
Self-citationImpact of neurofibromatosis 1 on Quality of Life: A cross‐sectional study of 176 American cases
Page, P. Z., Page, G. P., Écosse, E., Korf, B. R., Leplège, A., & Wolkenstein, P. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31422 · Cited by 151
Self-citationHow does the Schwann cell lineage form tumors in NF1?
Carroll, S. L., & Ratner, N. (2008) · Glia · doi:10.1002/glia.20776 · Cited by 148
Clinical and Genetic Characteristics of Patients with Neurofibromatosis Type 1 and Pheochromocytoma
Bausch, B., Borozdin, W., & Neumann, H. P. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmc066006 · Cited by 147
Decreased bone mineral density in patients with neurofibromatosis 1
Lammert, M., Kappler, M., Mautner, V., Lammert, K., Störkel, S., Friedman, J. M., & Atkins, D. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1940-2 · Cited by 143
Kuorilehto, T., Pöyhönen, M., Bloigu, R., Heikkinen, J. E., Väänänen, K., & Peltonen, J. T. K. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1801-4 · Cited by 139
Do NF1 gene deletions result in a characteristic phenotype?
Tonsgard, J. H., Yelavarthi, K. K., Cushner, S., Short, M. P., & Lindgren, V. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971128)73:1<80::aid-ajmg16>3.0.co;2-n · Cited by 139
Fottner, C., Helisch, A., Anlauf, M., Rossmann, H., Musholt, T., Kreft, A., Schadmand‐Fischer, S., Bartenstein, P., Lackner, K. J., Klöppel, G., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2352 · Cited by 137
Neoplasms Associated with Germline and Somatic NF1 Gene Mutations
Patil, S., & Chamberlain, R. S. (2012) · The Oncologist · doi:10.1634/theoncologist.2010-0181 · Cited by 135
Generalized metabolic bone disease in Neurofibromatosis type I
Brunetti‐Pierri, N., Doty, S. B., Hicks, J. M., Phan, K., Mendoza‐Londono, R., Blazo, M., Tran, A. A., Carter, S., Lewis, R. A., Plon, S. E., et al. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.12.004 · Cited by 123
Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1)
Tucker, T., Schnabel, C., Hartmann, M., Friedrich, R. E., Frieling, I., Hp, K., Mautner, V., & Friedman, J. M. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061895 · Cited by 111
Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects
Zinnamosca, L., Petramala, L., Cotesta, D., Marinelli, C., Schina, M., Cianci, R., Giustini, S., Sciomer, S., Anastasi, E., Calvieri, S., et al. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1090-z · Cited by 110
Malignant Peripheral Nerve Sheath Tumors
Weiss, B., Sheil, A. T., & Ratner, N. (2014) · Molecular pathology library · doi:10.1007/978-1-4939-1830-0_16 · Cited by 104
Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1
Lammert, M., Friedman, J. M., Roth, H. J., Friedrich, R. E., Kluwe, L., Atkins, D., Schooler, T., & Mautner, V. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.041095 · Cited by 100
van Minkelen, R., van Bever, Y., Kromosoeto, J. N. R., Withagen-Hermans, C., Nieuwlaat, A., Halley, D. J. J., & van den Ouweland, A. M. W. (2013) · Clinical Genetics · doi:10.1111/cge.12187 · Cited by 96
High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1
Seitz, S. A., Schnabel, C., Busse, B., Schmidt, H. U., Beil, F. T., Friedrich, R. E., Schinke, T., Mautner, V. F., & Amling, M. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0933-y · Cited by 90
Age-specific risk of breast cancer in women with neurofibromatosis type 1
Seminog, O. O., & Goldacre, M. J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.78 · Cited by 89
Cerebrovascular dysplasia in neurofibromatosis type 1
Cairns, A. G., & North, K. N. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.136457 · Cited by 88
Optimizing biologically targeted clinical trials for neurofibromatosis
Gutmann, D. H., Blakeley, J. O., Korf, B. R., & Packer, R. J. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.772979 · Cited by 85
Self-citationProgesterone receptor expression in neurofibromas.
McLaughlin, M. E., & Jacks, T. (2003) · PubMed · Cited by 83
Neurofibromatous neuropathy in neurofibromatosis 1 (NF1)
Ferner, R. E., Hughes, R. A. C., Hall, S. M., Upadhyaya, M., & Johnson, M. R. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.021683 · Cited by 82
Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1
Stewart, D. R., Sloan, J. L., Yao, L., Mannes, A. J., Moshyedi, A., Lee, C. R., Sciot, R., SMET, L. D., Mautner, V.-F., & Legius, E. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.073965 · Cited by 76
Self-citationHeervä, E., Koffert, A., Jokinen, E., Kuorilehto, T., Peltonen, S. A., Aro, H. T., & Peltonen, J. T. K. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1685 · Cited by 73
Meany, H. J., Dombi, E., Reynolds, J. C., Whatley, M. A., Kurwa, A., Tsokos, M., Salzer, W. L., Gillespie, A., Baldwin, A. M., Derdak, J., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24212 · Cited by 72
Neurofibromatosis type 1 and pregnancy complications: a population-based study
Terry, A. R., Barker, F. G., Leffert, L. R., Bateman, B. T., Souter, I. C., & Plotkin, S. R. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.03.029 · Cited by 70
Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1
Terry, A. R., Jordan, J. T., Schwamm, L. H., & Plotkin, S. R. (2015) · Stroke · doi:10.1161/strokeaha.115.011406 · Cited by 69
Treglia, G., Taralli, S., Bertagna, F., Salsano, M., Muoio, B., Novellis, P., Vita, M. L., Maggi, F., & Giordano, A. (2012) · Radiology Research and Practice · doi:10.1155/2012/431029 · Cited by 62
Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients
Lammert, M., Mautner, V., & Kluwe, L. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-16 · Cited by 61
Stewart, D. R., Cogan, J. D., Kramer, M. R., Miller, W. T., Christiansen, L. E., Pauciulo, M. W., Messiaen, L. M., Tu, G. S., Thompson, W. H., Pyeritz, R. E., et al. (2007) · CHEST Journal · doi:10.1378/chest.06-3017 · Cited by 61
Self-citationWang, X., Levin, A. M., Smolinski, S. E., Vigneau, F. D., Levin, N. K., & Tainsky, M. A. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35560 · Cited by 61
Sleep disturbance as part of the neurofibromatosis type 1 phenotype in adults
Leschziner, G. D., Golding, J. F., & Ferner, R. E. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35915 · Cited by 54
Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group
Descheemaeker, M., Plasschaert, E., Frijns, J., & Legius, E. (2012) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2012.01648.x · Cited by 54
Lierde, A. V., Menni, F., Bedeschi, M. F., Natacci, F., Guez, S., Vizziello, P., Costantino, M. A., Lalatta, F., & Esposito, S. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35982 · Cited by 49
Oates, E. C., Payne, J. M., Foster, S., Clarke, N. F., & North, K. N. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35840 · Cited by 45
BRCA1-Related Malignancies in a Family Presenting with von Recklinghausen's Disease
Ceccaroni, M., Genuardi, M., Legge, F., Cordisco, E. L., Carrara, S. C., D’Amico, F., Greggi, S., & Scambia, G. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6757 · Cited by 44
Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review
Crandall, C. J. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0282-z · Cited by 43
Madubata, C. C., Olsen, M. A. A., Stwalley, D. L., Gutmann, D. H., & Johnson, K. J. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.70 · Cited by 41
Impact of ADHD in Adults With Neurofibromatosis Type 1: Associated Psychological and Social Problems
Mautner, V.-F., Granström, S., & Leark, R. A. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712450749 · Cited by 39
Neuropathies in the setting of Neurofibromatosis tumor syndromes: Complexities and opportunities
Schulz, A., Grafe, P., Hagel, C., Bäumer, P., Morrison, H., Mautner, V., & Farschtschi, S. C. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.006 · Cited by 35
Neuropsychological Function in Adults With Von Recklinghausen's Neurofibromatosis
Pavol, M. A., Hiscock, M., Massman, P. J., Moore, B. D., Foorman, B. R., & Meyers, C. (2006) · Developmental Neuropsychology · doi:10.1207/s15326942dn2903_8 · Cited by 35
Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1
Merker, V. L., Murphy, T. P., Hughes, J. B., et al. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.11.021 · Cited by 33
Comparison of Clinical Risk Tools for Predicting Osteoporosis in Women Ages 50-64
Pecina, J. L., Romanovsky, L., Merry, S. P., Kennel, K. A., & Thacher, T. D. (2016) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2016.02.150237 · Cited by 31
Campos, B., Balmañà, J., Gardenyes, J., Valenzuela, I., Abad, O., Fàbregas, P., Volpini, V., & Dı́ez, O. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2538-6 · Cited by 30
Neurofibromatosis 1-Related Osteopenia Often Progresses to Osteoporosis in 12 Years
Heervä, E., Leinonen, P., Kuorilehto, T., Peltonen, S. A., Pöyhönen, M., Väänänen, K., & Peltonen, J. T. K. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9661-y · Cited by 29
Afridi, S. K., Leschziner, G. D., & Ferner, R. E. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37186 · Cited by 28
Heervä, E., Huilaja, L., Leinonen, P., Peltonen, S. A., & Peltonen, J. T. K. (2014) · Calcified Tissue International · doi:10.1007/s00223-013-9835-2 · Cited by 25
Prenatal diagnosis of neurofibromatosis type 1: sonographic and MRI findings
McEwing, R. L., Roume, J., Mohlo, M., Bernard, J. P., Hillion, Y., & Ville, Y. G. (2006) · Prenatal Diagnosis · doi:10.1002/pd.1560 · Cited by 24
Neuropsychological impairments in elderly Neurofibromatosis type 1 patients
Costa, D. D. S., de Paula, J. J., de Rezende, N. A., Rodrigues, L. O. C., Malloy‐Diniz, L. F., Romano‐Silva, M. A., & de Miranda, D. M. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2014.02.004 · Cited by 23
Heervä, E., Peltonen, S. A., Svedström, E., Aro, H. T., Väänänen, K., & Peltonen, J. T. K. (2011) · Bone · doi:10.1016/j.bone.2011.12.011 · Cited by 20
Neurofibromatosis type I with breast cancer: not only for women!
Lakshmaiah, K. C., Kumar, A., Purohit, S., Kalegowda, V. B., Rajan, K. R., Zameer, M. A. L., Prabhu, N., Saini, M. L., Azim, H. A., & Saini, K. S. (2014) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-12-5 · Cited by 16
Association of Pheochromocytoma and Ganglioneuroma: Unusual Finding in Neurofibromatosis Type 1
Mezitis, S. G. E., Geller, M., Bocchieri, E., Pizzo, J. D., & Merlin, S. (2007) · Endocrine Practice · doi:10.4158/ep.13.6.647 · Cited by 12
Cited by
Lin, A. E., Prakash, S. K., Andersen, N. H., Viuff, M. H., Levitsky, L. L., Rivera‐Davila, M., Crenshaw, M. L., Hansen, L., Colvin, M. K., Hayes, F. J., et al. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61310 · Cited by 50
Metadata
- Authors
- Stewart, D. R., Korf, B. R., Nathanson, K. L., Stevenson, D. A., & Yohay, K.
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 20
- Issue
- 7
- Pages
- 671-682
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W2801840800
- Cited by
- 202
- References
- 91
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.